NEUROLEPTIC MALIGNANT SYNDROME - CONTROVERSIES IN TREATMENT

被引：4

作者：

SCHNEIDER, SM

机构：

[1] Medical Emergency Services, Department of Medicine, Montefiore University Hospital, Pittsburgh, PA

来源：

关键词：

D O I：

10.1016/0735-6757(91)90058-R

中图分类号：

R4 [临床医学];

学科分类号：

1002 ; 100602 ;

摘要：

[No abstract available]

引用

页码：360 / 362

页数：3

共 37 条

[1]

Delay, Deniker, Drug-induced extra pyramidal syndromes, Diseases of the Basal Ganglia, 6, (1968)

[2]

Guze, Baxter, Current concepts: Neuroleptic malignant syndrome, N Engl J Med, 313, pp. 163-166, (1985)

[3]

Caroff, The neuroleptic malignant syndrome, J Clin Psychiatry, 41, pp. 79-83, (1980)

[4]

Levinson, Neuroleptic malignant syndrome, Am J Psychiatry, 142, pp. 1137-1145, (1985)

[5]

Olmsted, Neuroleptic malignant syndrome: Guidelines for treatment and reinstitution of neuroleptics, S Med J, 81, pp. 888-891, (1988)

[6]

Keck, Pope, Cohen, Et al., Risk factors for neuroleptic malignant syndrome, Arch Gen Psychiatry, 46, pp. 914-918, (1989)

[7]

Cox, Kerwin, Lee, Dopamine receptors in the central thermoregulatory pathways of the rat, J Physiol, 282, pp. 471-483, (1978)

[8]

Kennedy, Burks, Dopamine receptors in the central thermoregulatory mechanism of the cat, Neuropharmacology, 13, pp. 119-128, (1974)

[9]

Chamorwitz, Gomes, Maze, Neuroleptic malignant syndrome, Can Med Assoc J, 138, pp. 51-53, (1988)

[10]

Henderson, Wooten, Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade?, Neurology, 31, pp. 132-137, (1981)